5% stakes
Lynx1 Capital Management
Institution
- 5% stake reports
- 31
- 5% stake stocks
- 12
- Latest report
- 26/08/14
5% stake reports
| Stock | ||
|---|---|---|
| TScan Therapeutics TCRX08/14 | 13.1%20,519,148 sh | −1.9pp |
| Stoke Therapeutics STOK08/14 | 6.5%4,038,404 sh | −1.6pp |
| C4 Therapeutics CCCC08/14 | 9.99%15,423,691 sh | +2.7pp |
| iBio08/14 | 5.4%2,807,016 sh | +5.4pp |
| GH Research GHRS08/14 | 19.3%13,263,288 sh | +1.9pp |
| Precision Biosciences DTIL07/20 | 5.4%1,390,611 sh | +1.3pp |
| Passage BIO PASG07/02 | 21%673,759 sh | +1.4pp |
| GH Research GHRS05/18 | 17.4%10,763,288 sh | +2.2pp |
| Stoke Therapeutics STOK05/18 | 8.1%4,763,673 sh | +1.1pp |
| Allogene Therapeutics ALLO05/15 | 0%0 sh | −5.2pp |
| GH Research GHRS05/15 | 15.2%9,456,622 sh | −1.6pp |
| Agios Pharmaceuticals AGIO05/06 | 5.1%3,013,949 sh | First report |
| Korro Bio KRRO04/02 | 10.7%1,538,296 sh | +2.9pp |
| Precision Biosciences DTIL02/17 | 4.1%993,913 sh | −4.7pp |
| GH Research GHRS02/17 | 16.8%10,406,575 sh | +2.9pp |
| Korro Bio KRRO01/05 | 7.8%733,633 sh | First report |
| Neuphoria Therapeutics NEUP25/12/29 | 16.3%875,328 sh | +0.0pp |
| Neuphoria Therapeutics NEUP25/12/02 | 16.3%875,328 sh | +0.0pp |
| Neuphoria Therapeutics NEUP25/11/28 | 16.3%875,328 sh | +0.0pp |
| Neuphoria Therapeutics NEUP25/11/18 | 16.3%875,328 sh | −10.2pp |
